Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016

Publisher Name :
Date: 14-Sep-2016
No. of pages: 402

Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016" provides an overview of Injectable Drug Delivery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Injectable Drug Delivery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Injectable Drug Delivery under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Injectable Drug Delivery and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Injectable Drug Delivery under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 19
2 Introduction 20
2.1 Injectable Drug Delivery Overview 20
3 Products under Development 21
3.1 Injectable Drug Delivery - Pipeline Products by Stage of Development 21
3.2 Injectable Drug Delivery - Pipeline Products by Segment 22
3.3 Injectable Drug Delivery - Pipeline Products by Territory 23
3.4 Injectable Drug Delivery - Pipeline Products by Regulatory Path 24
3.5 Injectable Drug Delivery - Pipeline Products by Estimated Approval Date 25
3.6 Injectable Drug Delivery - Ongoing Clinical Trials 26
4 Injectable Drug Delivery - Pipeline Products under Development by Companies 27
4.1 Injectable Drug Delivery Companies - Pipeline Products by Stage of Development 27
4.2 Injectable Drug Delivery - Pipeline Products by Stage of Development 31
5 Injectable Drug Delivery Companies and Product Overview 35
5.1 Aciont Inc. Company Overview 35
5.2 Actavis Inc. Company Overview 37
5.3 AdrenaCard, Inc. Company Overview 38
5.4 Allergan, Inc. Company Overview 39
5.5 Alsensa ApS Company Overview 40
5.6 AMAG Pharmaceuticals, Inc. Company Overview 41
5.7 Amgen Inc. Company Overview 43
5.8 Antares Pharma, Inc. Company Overview 45
5.9 Anterion Therapeutics, Inc. (Inactive) Company Overview 51
5.10 Arnali, LLC Company Overview 54
5.11 Artemes Technologies, Inc. Company Overview 55
5.12 AstraZeneca Plc Company Overview 56
5.13 Atanse, Inc. Company Overview 58
5.14 AzureBio, S.L. Company Overview 60
5.15 Becton, Dickinson and Company Company Overview 61
5.16 Bespak Europe Ltd. Company Overview 65
5.17 Biodel Inc. Company Overview 68
5.18 BioMarin Pharmaceutical Inc. Company Overview 70
5.19 BioRestorative Therapies, Inc. Company Overview 72
5.20 Boston University Company Overview 74
5.21 BTG Plc Company Overview 75
5.22 Burke Pharmaceuticals, LLC Company Overview 77
5.23 Callisyn Biomedical Inc Company Overview 78
5.24 Cambridge Consultants Limited Company Overview 81
5.25 Case Western Reserve University Company Overview 82
5.26 Cincinnati Children's Hospital Medical Center Company Overview 83
5.27 Clearside BioMedical, Inc. Company Overview 84
5.28 Consort Medical plc Company Overview 88
5.29 Credence MedSystems, Inc. Company Overview 89
5.30 CrossCoat Medical LLC Company Overview 90
5.31 Cytosial Biomedic, S.a.s. Company Overview 91
5.32 DALI Medical Devices Ltd. Company Overview 92
5.33 Delcath Systems, Inc. Company Overview 96
5.34 DelSite, Inc. (Inactive) Company Overview 101
5.35 Elcam Medical Company Overview 102
5.36 EmboMedics Company Overview 106
5.37 Emergent BioSolutions Inc. Company Overview 107
5.38 Eveon SAS Company Overview 109
5.39 Ghent University Company Overview 110
5.40 Hannover Medical School Company Overview 111
5.41 Indian Institute of Science Company Overview 112
5.42 Inovio Pharmaceuticals, Inc. Company Overview 113
5.43 LyoGo Company Overview 115
5.44 Medicom Innovation Partner a/s Company Overview 116
5.45 Meridian Medical Technologies, Inc. Company Overview 117
5.46 Mertiva AB Company Overview 118
5.47 Microchips Biotech, Inc. Company Overview 119
5.48 Midatech Pharma Plc Company Overview 121
5.49 Milestone Scientific Inc. Company Overview 123
5.50 North Carolina State University Company Overview 126
5.51 Ocelus Company Overview 128
5.52 Oval Medical Technologies Limited Company Overview 129
5.53 Particle Therapeutics Ltd Company Overview 130
5.54 Pfizer Inc. Company Overview 131
5.55 Portal Instruments, Inc. Company Overview 133
5.56 pSivida Corp. Company Overview 134
5.57 Ratio, Inc. Company Overview 139
5.58 Recon Therapeutics, LLC Company Overview 141
5.59 Replenish Inc Company Overview 142
5.60 RepliCel Life Sciences, Inc. Company Overview 144
5.61 RetinaPharma Technologies, Inc. Company Overview 145
5.62 Rx Safes, Inc. Company Overview 146
5.63 Scandinavian Health Ltd Company Overview 147
5.64 Shire Plc Company Overview 148
5.65 Spine Smith, LP Company Overview 150
5.66 Sun Pharmaceutical Industries Limited Company Overview 151
5.67 TCB medical devices Company Overview 153
5.68 Teva Pharmaceutical Industries Ltd. Company Overview 154
5.69 Texas Tech University Company Overview 156
5.70 TheraKine Ltd. (Inactive) Company Overview 157
5.71 Unilife Corporation Company Overview 159
5.72 United Therapeutics Corporation Company Overview 162
5.73 University College London Company Overview 164
5.74 University of Auckland Company Overview 165
5.75 University of Calgary Company Overview 166
5.76 University of California, Irvine Company Overview 167
5.77 University of California, San Diego Company Overview 168
5.78 University of California, San Francisco Company Overview 169
5.79 University of Delaware Company Overview 170
5.80 University of Dundee Company Overview 171
5.81 University of Florida Company Overview 172
5.82 University of Missouri Company Overview 175
5.83 University of Saskatchewan Company Overview 176
5.84 University of Texas at Austin Company Overview 177
5.85 Urodelia SA Company Overview 179
5.86 Vanderbilt University Company Overview 180
6 Injectable Drug Delivery- Recent Developments 181
6.1 Aug 29, 2016: Mylan to Launch First Generic to EpiPen Auto-Injector at a List Price of $300 per Two-Pack Carton, a More than 50% Discount to the Brand Product 181
6.2 Aug 29, 2016: pSivida Announces 13 New Patents Issued or Allowed 182
6.3 Aug 29, 2016: Catalent Reports Fourth Quarter and Fiscal Year 2016 Results 182
6.4 Aug 25, 2016: Mylan Taking Immediate Action To Further Enhance Access To EpiPen (Epinephrine Injection, USP) Auto-Injector 185
6.5 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 186
6.6 Aug 24, 2016: Senators Ask FDA to Account for Any Alternatives to the EpiPen Amid Product Cost Increases 188
6.7 Aug 24, 2016: Hillary Clinton Statement on EpiPen Pricing 189
6.8 Aug 24, 2016: Milestone Scientific Begins Transition From a Product Development to a Business Development Company 189
6.9 Aug 22, 2016: Mylan's Commitment to EpiPen (epinephrine injection, USP) Auto-Injector Access 190
6.10 Aug 17, 2016: Consort Medical Announces Directorate Change 191
6.11 Aug 16, 2016: Delcath Announces Second Quarter Financial Results 192
6.12 Aug 15, 2016: MRI Interventions Announces 2016 Second Quarter and Six Month Results 193
6.13 Aug 12, 2016: Milestone Scientific Reports 34% Increase in Revenue for the Second Quarter of 2016 197
6.14 Aug 11, 2016: Biodel Reports Third Quarter Fiscal Year 2016 Financial Results 198
6.15 Aug 11, 2016: Clearside Biomedical Reports Second Quarter 2016 Financial Results 198
6.16 Aug 09, 2016: Primary Endpoint Met in pSivida's Utilization Study of New Medidur Inserter with Smaller Diameter Needle 199
6.17 Aug 09, 2016: BioMarin Pharma Prices Public Offering of Shares for USD720 Million 200
6.18 Aug 09, 2016: Mylan Reports Strong Second Quarter 2016 Results Including Total Revenues Up 8% 200
6.19 Aug 09, 2016: Antares Pharma Reports Second Quarter 2016 Operating and Financial Results 203
6.20 Aug 09, 2016: Halozyme Reports Second Quarter 2016 Financial Results 205
6.21 Aug 05, 2016: Caverion delivers a Large Project for Novo Nordisk's new insulin production facility in Hillerod, Denmark 206
6.22 Aug 05, 2016: Novo Nordisk increased adjusted operating profit by 8% in local currencies in the first six months of 2016 207
6.23 Aug 04, 2016: Teva Reports Second Quarter 2016 Results 207
6.24 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 212
6.25 Aug 04, 2016: Merck Lifts Forecast Following Good Second Quarter 213
6.26 Aug 04, 2016: Emergent BioSolutions Reports Second Quarter and Six Months 2016 Financial Results 216
6.27 Aug 03, 2016: pSivida Names Dario Paggiarino, M.D. as Chief Medical Officer 219
6.28 Aug 02, 2016: Merck and Allergan May Acquire Biogen 219
6.29 Aug 02, 2016: Pfizer Reports Second-Quarter 2016 Results 219
6.30 Aug 02, 2016: Shire Delivers Strong Q2 2016 Revenue Growth; Upgrades Outlook 223
6.31 Aug 01, 2016: BCWorld Pharm Raises USD1.8 Million in Private Placement of Shares 228
6.32 Aug 01, 2016: Aptevo Therapeutics Completes Separation from Emergent BioSolutions 228
6.33 Aug 01, 2016: Clearside Biomedical Announces Promotion of Glenn Noronha, Ph.D. to Chief Scientific Officer and Jennifer M. Kissner, Ph.D. to Vice President, Clinical Development 228
6.34 Aug 01, 2016: Emergent BioSolutions Completes Spin-Off of Aptevo Therapeutics 229
7 Appendix 397
7.1 Methodology 397
7.2 About GlobalData 399
7.3 Contact Us 399
7.4 Disclaimer 400

1.1 List of Tables
Table 1: Injectable Drug Delivery - Pipeline Products by Stage of Development 23
Table 2: Injectable Drug Delivery - Pipeline Products by Segment 24
Table 3: Injectable Drug Delivery - Pipeline Products by Territory 25
Table 4: Injectable Drug Delivery - Pipeline Products by Regulatory Path 26
Table 5: Injectable Drug Delivery - Pipeline Products by Estimated Approval Date 27
Table 6: Injectable Drug Delivery - Ongoing Clinical Trials 28
Table 7: Injectable Drug Delivery Companies - Pipeline Products by Stage of Development 29
Table 8: Injectable Drug Delivery - Pipeline Products by Stage of Development 33
Table 9: Aciont Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 10: DSP - Visulex - Product Status 37
Table 11: DSP - Visulex - Product Description 38
Table 12: Visulex-I - Product Status 38
Table 13: Visulex-I - Product Description 38
Table 14: Actavis Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
Table 15: Epinephrine Pre-Filled Syringe - Product Status 39
Table 16: Epinephrine Pre-Filled Syringe - Product Description 39
Table 17: AdrenaCard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 18: Adrenacard Auto-Injector - Product Status 40
Table 19: Adrenacard Auto-Injector - Product Description 40
Table 20: Allergan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 21: NOVADUR Intravitreal Implant - Product Status 41
Table 22: NOVADUR Intravitreal Implant - Product Description 41
Table 23: Alsensa ApS Pipeline Products & Ongoing Clinical Trials Overview 42
Table 24: SQJCT - Product Status 42
Table 25: SQJCT - Product Description 42
Table 26: AMAG Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
Table 27: Makena Auto-Injector - Product Status 43
Table 28: Makena Auto-Injector - Product Description 44
Table 29: Amgen Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
Table 30: Repatha Pushtronex System - Product Status 45
Table 31: Repatha Pushtronex System - Product Description 46
Table 32: Antares Pharma, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
Table 33: Teva Pen 1 - Product Status 47
Table 34: Teva Pen 1 - Product Description 48
Table 35: Vibex EPI - Product Status 48
Table 36: Vibex EPI - Product Description 48
Table 37: Vibex Mini-Needle Injectors - Product Status 49
Table 38: Vibex Mini-Needle Injectors - Product Description 49
Table 39: Vibex Qs - Next Generation Makena - Product Status 49
Table 40: Vibex Qs - Next Generation Makena - Product Description 50
Table 41: Vibex QS M - Product Status 50
Table 42: Vibex QS M - Product Description 50
Table 43: Vibex QS T - Product Status 51
Table 44: Vibex QS T - Product Description 51
Table 45: VIBEX Sumatriptan - Product Status 51
Table 46: VIBEX Sumatriptan - Product Description 52
Table 47: Anterion Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53
Table 48: Ambulin - Product Status 53
Table 49: Ambulin - Product Description 53
Table 50: Choless - Product Status 54
Table 51: Choless - Product Description 54
Table 52: Complimens - Product Status 54
Table 53: Complimens - Product Description 55
Table 54: Arnali, LLC Pipeline Products & Ongoing Clinical Trials Overview 56
Table 55: Arnali Drug Delivery Device - Product Status 56
Table 56: Arnali Drug Delivery Device - Product Description 56
Table 57: Artemes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
Table 58: Artemes Magnetic Injection System - Product Status 57
Table 59: Artemes Magnetic Injection System - Product Description 57
Table 60: AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview 58
Table 61: Second Generation Bydureon Pen - Product Status 58
Table 62: Second Generation Bydureon Pen - Product Description 59
Table 63: Atanse, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
Table 64: CEDSYS - Product Status 60
Table 65: CEDSYS - Product Description 60
Table 66: Intracerebral Microinjection Instrument - Product Status 61
Table 67: Intracerebral Microinjection Instrument - Product Description 61
Table 68: AzureBio, S.L. Pipeline Products & Ongoing Clinical Trials Overview 62
Table 69: Injectable Needle - Product Status 62
Table 70: Injectable Needle - Product Description 62
Table 71: Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 63
Table 72: BD Libertas Patch Injector - Product Status 63
Table 73: BD Libertas Patch Injector - Product Description 64
Table 74: BD Physioject Disposable AutoInjector - Product Status 64
Table 75: BD Physioject Disposable AutoInjector - Product Description 64
Table 76: BD Simplist Prefilled Injectable - Heparin Sodium - Product Status 65
Table 77: BD Simplist Prefilled Injectable - Heparin Sodium - Product Description 65
Table 78: BD Simplist Prefilled Injectable - Hydromorphone Hydrochloride - Product Status 65
Table 79: BD Simplist Prefilled Injectable - Hydromorphone Hydrochloride - Product Description 66
Table 80: Bespak Europe Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
Table 81: INJ570 Autoinjector - Product Status 67
Table 82: INJ570 Autoinjector - Product Description 67
Table 83: INJ650 ASI Auto-Injector - Product Status 68
Table 84: INJ650 ASI Auto-Injector - Product Description 68
Table 85: INJ700 Lila Mix Injector - Product Status 68
Table 86: INJ700 Lila Mix Injector - Product Description 69
Table 87: Biodel Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
Table 88: EZMix Glucagon Rescue Device - Product Status 70
Table 89: EZMix Glucagon Rescue Device - Product Description 71
Table 90: BioMarin Pharmaceutical Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
Table 91: PEG PAL Pre-filled Syringe - Product Status 72
Table 92: PEG PAL Pre-filled Syringe - Product Description 73
Table 93: BioRestorative Therapies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
Table 94: brtxDISC Stem Cell Delivery Device - Product Status 74
Table 95: brtxDISC Stem Cell Delivery Device - Product Description 75
Table 96: Boston University Pipeline Products & Ongoing Clinical Trials Overview 76
Table 97: Polymeric Drug Delivery System - Product Status 76
Table 98: Polymeric Drug Delivery System - Product Description 76
Table 99: BTG Plc Pipeline Products & Ongoing Clinical Trials Overview 77
Table 100: Varithena - Product Status 77
Table 101: Varithena - Product Description 78
Table 102: Varithena - Aesthetic Leg Veins - Product Status 78
Table 103: Varithena - Aesthetic Leg Veins - Product Description 78
Table 104: Burke Pharmaceuticals, LLC Pipeline Products & Ongoing Clinical Trials Overview 79
Table 105: BURKE201 Needle Injection Pen - Product Status 79
Table 106: BURKE201 Needle Injection Pen - Product Description 79
Table 107: Callisyn Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 80
Table 108: 8Spheres Embolic Microspheres - Product Status 80
Table 109: 8Spheres Embolic Microspheres - Product Description 81
Table 110: Callispheres PVA Embolic Microspheres - Product Status 81
Table 111: Callispheres PVA Embolic Microspheres - Product Description 81
Table 112: TACEspheres Drug Eluting Embolic Microspheres - Product Status 82
Table 113: TACEspheres Drug Eluting Embolic Microspheres - Product Description 82
Table 114: Cambridge Consultants Limited Pipeline Products & Ongoing Clinical Trials Overview 83
Table 115: Flexi-ject - Product Status 83
Table 116: Flexi-ject - Product Description 83
Table 117: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 84
Table 118: Pressure Driven Local Drug Delivery System - Liver Cancer - Product Status 84
Table 119: Pressure Driven Local Drug Delivery System - Liver Cancer - Product Description 84
Table 120: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 85
Table 121: Pre-Filled Syringe With Flush - Product Status 85
Table 122: Pre-Filled Syringe With Flush - Product Description 85
Table 123: Clearside BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
Table 124: SCS Microinjector - Product Status 86
Table 125: SCS Microinjector - Product Description 87
Table 126: Clearside BioMedical, Inc. - Ongoing Clinical Trials Overview 88

1.2 List of Figures
Figure 1: Injectable Drug Delivery - Pipeline Products by Stage of Development 23
Figure 2: Injectable Drug Delivery - Pipeline Products by Segment 24
Figure 3: Injectable Drug Delivery - Pipeline Products by Territory 25
Figure 4: Injectable Drug Delivery - Pipeline Products by Regulatory Path 26
Figure 5: Injectable Drug Delivery - Pipeline Products by Estimated Approval Date 27
Figure 6: Injectable Drug Delivery - Ongoing Clinical Trials 28
  • Global Luxury Apparels Market To Do Well Owing To Numerous International Brands
    The global luxury apparels market is fired by the intensifying number of fashion marques and many designers getting wide-ranging clienteles in the form of cost-effective products. The global luxury apparels market was at US$1, 8842.69 million in 2015 and is forecast to reach US$60,793.7 million by the end of 2024. This segment of luxury goods [...]
  • Global Health and Wellness Market Boosted By Organic Products and Wearables
    Healthcare has constantly been a profitable area where buyers spend belligerently. But now, with increasing disposable earnings amid the city population and ground-breaking approaches and innovative products being developed, the overall health and wellness market is estimated for a healthy prospect. The health and wellness market is presently very dynamic owing to growing alertness amongst [...]
  • Increasing New Outlets And Striking Offers To Drive Global Pizza Market
    The global pizza market is predicted to grow at a steady CAGR of about 3% by 2020. Pizza has been gaining massive acceptance globally in the last few years. Consequently, the global pizza market is anticipated to observer considerable progress in the coming years. The growing number of pizzerias is one of the major elements [...]
  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Global Intrathecal Pumps Market Research Report 2016
    Published: 01-Dec-2016        Price: US 2900 Onwards        Pages: 112
    Notes: Production, means the output of Intrathecal Pumps Revenue, means the sales value of Intrathecal Pumps This report studies Intrathecal Pumps in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Codman & Shurtleff - Medtronic - Flowonix Medical - Teleflex - S......
  • Global Drug Delivery Devices Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 30-Nov-2016        Price: US 3480 Onwards        Pages: 113
    Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.Scope of the Report:This report focuses on the Drug Delivery Devices in Global market, especially in ......
  • Global Injectable Drug Delivery Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 19-Nov-2016        Price: US 3480 Onwards        Pages: 116
    Injectable drug delivery is defined as administration of a drug or drugs directly into patient's blood circulationthrough a delivery device. It is considered as the most common and effective route of administration of most therapeutic agents to achieve the desired quick response. The injectable route of drug administration is expected to continue to be an important delivery system. This has been attributed to reasons that injectable drug delivery system allows administration of drugs with poor o......
  • Global Intrathecal Pumps Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 19-Nov-2016        Price: US 3480 Onwards        Pages: 100
    An intrathecal pump is a medical device used to deliver medications directly into the space between the spinal cord and the protective sheath surrounding the spinal cord. Medications such as baclofen, morphine, or ziconotide may be delivered in this manner to minimize the side effects often associated with the higher doses used in oral or intravenous delivery of these drugs.Scope of the Report:This report focuses on the Intrathecal Pumps in Global market, especially in Nor......
  • Global Pulmonary Drug Delivery Systems Market Research Report 2016
    Published: 26-Oct-2016        Price: US 2900 Onwards        Pages: 111
    Notes: Production, means the output of Pulmonary Drug Delivery Systems Revenue, means the sales value of Pulmonary Drug Delivery Systems This report studies Pulmonary Drug Delivery Systems in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - 3M - GSK - AstraZeneca - Cipl......
  • United States Metered Dose Inhaler Devices Market Report 2016
    Published: 26-Oct-2016        Price: US 3800 Onwards        Pages: 99
    Notes: Sales, means the sales volume of Metered Dose Inhaler Devices Revenue, means the sales value of Metered Dose Inhaler Devices This report studies sales (consumption) of Metered Dose Inhaler Devices in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Aerophase - Bang & Olufsen Medicom - Bespak Europe - Globe Medical - Lab Automate Technologies - Myl......
  • Global Inhalation Therapy Nebulizer Sales Market Report 2016
    Published: 25-Oct-2016        Price: US 4000 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Inhalation Therapy Nebulizer Revenue, means the sales value of Inhalation Therapy Nebulizer This report studies sales (consumption) of Inhalation Therapy Nebulizer in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - PARI GmbH - Medel S.p.A - San Up S.A......
  • Global Intranasal Drug Delivery Devices Market Research Report 2016
    Published: 24-Oct-2016        Price: US 2900 Onwards        Pages: 104
    Notes: Production, means the output of Intranasal Drug Delivery Devices Revenue, means the sales value of Intranasal Drug Delivery Devices This report studies Intranasal Drug Delivery Devices in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Teleflex - OptiNose - Kurve Techn......
  • Global Drug Delivery Devices Market Professional Survey Report 2016
    Published: 24-Oct-2016        Price: US 3500 Onwards        Pages: 122
    Notes: Production, means the output of Drug Delivery Devices Revenue, means the sales value of Drug Delivery Devices This report studies Drug Delivery Devices in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, rev......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs